Els F. Halff

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Health behaviours and telomere biology in severe mental disorders.

Health behaviours and telomere biology in severe mental disorders.

Journal: Translational psychiatry

Published: October 16, 2025

TAAR1 Regulates Presynaptic Dopamine Function: Evidence From Preclinical Studies and a Phase 1b Trial in Patients With Schizophrenia.

TAAR1 Regulates Presynaptic Dopamine Function: Evidence From Preclinical Studies and a Phase 1b Trial in Patients With Schizophrenia.

Journal: Biological psychiatry

Published: May 08, 2025

Coffee intake is associated with telomere length in severe mental disorders.

Coffee intake is associated with telomere length in severe mental disorders.

Journal: BMJ mental health

Published: March 26, 2025

Effect of the TAAR1 Partial Agonist Ralmitaront on Presynaptic Dopamine Synthesis Capacity Measured Using [18F]DOPA PET in Naïve and Cocaine-Treated Mice.

Effect of the TAAR1 Partial Agonist Ralmitaront on Presynaptic Dopamine Synthesis Capacity Measured Using [18F]DOPA PET in Naïve and Cocaine-Treated Mice.

Journal: Molecular imaging

Published: June 10, 2024

Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.

Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.

Journal: Molecular imaging and biology

Published: April 03, 2024

Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition.

Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition.

Journal: Schizophrenia research

Published: March 12, 2024

Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.

Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.

Journal: Molecular imaging and biology

Published: August 07, 2023

Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders.

Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders.

Journal: Trends in neurosciences

Published: July 21, 2022

Evaluation of Intraperitoneal [18F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.

Evaluation of Intraperitoneal [18F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.

Journal: Molecular imaging

Published: July 19, 2022

Phosphorylation of neuroligin-2 by PKA regulates its cell surface abundance and synaptic stabilization.

Phosphorylation of neuroligin-2 by PKA regulates its cell surface abundance and synaptic stabilization.

Journal: Science signaling

Published: June 21, 2022

Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortex.

Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortex.

Journal: Behavioural brain research

Published: December 01, 2020

Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.

Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.

Journal: Nature communications

Published: June 27, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026